Limited Passive Diffusion of Apolipoprotein E Across the Human Blood–CSF Barrier: Evidence From Paired CSF /Serum Quotients
Journal of Neurochemistry · 2026-11 · 170 (11)
DOI: 10.1111/jnc.70585 ↗Abstract
ABSTRACT Apolipoprotein E (ApoE) is a major genetic risk factor for sporadic Alzheimer's disease and a potential therapeutic target, but the relative contribution of peripheral blood‐derived and intrathecally synthesized ApoE to the CNS remains unclear. A novel electrophoresis‐based capillary Western blot assay was validated to quantify Pan‐ApoE and ApoE4 in paired human CSF and serum samples ( n = 34), followed by analysis of CSF/serum quotients. Serum ApoE concentrations were ninefold higher than CSF concentrations, with CSF/serum quotients of 0.132 for Pan‐ApoE and 0.191 for ApoE4. Compared with theoretical quotients predicted for proteins entering CSF solely by passive diffusion according to their hydrodynamic radius according to Felgenhauer et al., the observed quotients were 66‐ to 1320‐fold higher for Pan‐ApoE and 96‐ to 1910‐fold higher for ApoE4. Based on this model, passive diffusion was estimated to account for less than 1.5% of CSF ApoE. These estimates are model‐dependent and may vary with ApoE isoform and extent of lipidation, which could potentially be affected by serum fibrin clot formation. The remaining ApoE fraction (> 98.5%) may reflect active transport, intrathecal synthesis or both. Pan‐ApoE and ApoE4 CSF/serum quotients lacked statistically significant association with CSF/serum albumin quotient as a marker of blood‐CSF barrier function. Both quotients also exceeded the values predicted by a theoretical reference curve relating CSF/serum protein quotients to the albumin quotient, adapted from the Reiber model using immunoglobulin G parameters based on the comparable hydrodynamic radii of IgG and ApoE. image
EUVIMED